Karin Mellström

Karin Mellström has over 20 years of experience from the life sciences industry. She acted as a senior project manager and head of the cell biology department at KaroBio AB and KabiGen AB. She has been a project leader at Avaris AB and held a project coordinator position at Karolinska University Hospital and Karolinska Institutet with the aim of facilitating the development of cell therapies. Karin Mellström served as CEO of XNK Therapeutics from 2012 to 2020, when she assumed the role of Senior Advisor. She has vast experience from project management, drug development and clinical trials. She has been involved in several international collaborations with Big Pharma.